These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 1373064)

  • 41. Zidovudine in asymptomatic human immunodeficiency virus infection. A controlled trial in persons with fewer than 500 CD4-positive cells per cubic millimeter. The AIDS Clinical Trials Group of the National Institute of Allergy and Infectious Diseases.
    Volberding PA; Lagakos SW; Koch MA; Pettinelli C; Myers MW; Booth DK; Balfour HH; Reichman RC; Bartlett JA; Hirsch MS
    N Engl J Med; 1990 Apr; 322(14):941-9. PubMed ID: 1969115
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Partial restoration of impaired interleukin-2 production and Tac antigen (putative interleukin-2 receptor) expression in patients with acquired immune deficiency syndrome by isoprinosine treatment in vitro.
    Tsang KY; Fudenberg HH; Galbraith GM; Donnelly RP; Bishop LR; Koopmann WR
    J Clin Invest; 1985 May; 75(5):1538-44. PubMed ID: 2581997
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Immunological effects of isoprinosine as a pulse immunotherapy in melanoma and ARC patients.
    Pompidou A; Soubrane C; Cour V; Telvi L; Meunier C; Jacquillat C
    Cancer Detect Prev Suppl; 1987; 1():457-62. PubMed ID: 2446759
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Therapeutic efficacy of inosiplex (Isoprinosine) in rhinovirus infection.
    Waldman RH; Ganguly R
    Ann N Y Acad Sci; 1977 Mar; 284():153-60. PubMed ID: 81636
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Eight year prospective study of HIV infection in a cohort of homosexual men--clinical progression, immunological and virological markers.
    Lau RK; Hill A; Jenkins P; Caun K; Forster SM; Weber JN; McManus TJ; Harris JR; Jeffries DJ; Pinching AJ
    Int J STD AIDS; 1992; 3(4):261-6. PubMed ID: 1504157
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Acquired immunodeficiency syndrome (AIDS) risk in recent and long-standing human immunodeficiency virus type 1 (HIV-1)-infected patients with similar CD4 lymphocyte counts.
    Phillips AN; Sabin CA; Elford J; Bofill M; Janossy G; Lee CA
    Am J Epidemiol; 1993 Nov; 138(10):870-8. PubMed ID: 7901990
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Influence of methisoprinol (isoprinosine) on HIV-infected human lymphocytes: in vitro immunological, virological, and ultrastructural studies.
    De Simone C; De Marco F; Arancia G; Tzantzoglou S; Paradisi S; Sorice F
    J Clin Lab Anal; 1989; 3(1):26-33. PubMed ID: 2469781
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Interferon-alpha in patients with asymptomatic human immunodeficiency virus (HIV) infection. A randomized, placebo-controlled trial.
    Lane HC; Davey V; Kovacs JA; Feinberg J; Metcalf JA; Herpin B; Walker R; Deyton L; Davey RT; Falloon J
    Ann Intern Med; 1990 Jun; 112(11):805-11. PubMed ID: 1971503
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Occurrence of HIV antigens in patients with acquired immunodeficiency syndrome].
    Radkowski M; Laskus T; Kopicz-Kamińska E; Babiuch L; Slusarczyk J
    Pol Arch Med Wewn; 1991 Dec; 86(6):366-71. PubMed ID: 1687897
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Maintenance of CD4+ cells by thymopentin in asymptomatic HIV-infected subjects: results of a double-blind, placebo-controlled study.
    Conant MA; Calabrese LH; Thompson SE; Poiesz BJ; Rasheed S; Hirsch RL; Meyerson LA; Kremer AB; Wang CC; Goldstein G
    AIDS; 1992 Nov; 6(11):1335-9. PubMed ID: 1361746
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Combined use of isoprinosine and an interferon inducer in experimental viral infection].
    Fomina AN; Grigorian SS; Nikolaeva OV; Ershov FI
    Antibiotiki; 1980 Nov; 25(11):854-7. PubMed ID: 6160806
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Randomised, double-blind, placebo-controlled trial of ditiocarb sodium ('Imuthiol') in human immunodeficiency virus infection.
    Lang JM; Touraine JL; Trepo C; Choutet P; Kirstetter M; Falkenrodt A; Herviou L; Livrozet JM; Retornaz G; Touraine F
    Lancet; 1988 Sep; 2(8613):702-6. PubMed ID: 2901566
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Predicting progression to AIDS: combined usefulness of CD4 lymphocyte counts and p24 antigenemia.
    MacDonell KB; Chmiel JS; Poggensee L; Wu S; Phair JP
    Am J Med; 1990 Dec; 89(6):706-12. PubMed ID: 1979205
    [TBL] [Abstract][Full Text] [Related]  

  • 54. CD4+ lymphocytes are an incomplete surrogate marker for clinical progression in persons with asymptomatic HIV infection taking zidovudine.
    Choi S; Lagakos SW; Schooley RT; Volberding PA
    Ann Intern Med; 1993 May; 118(9):674-80. PubMed ID: 8096373
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Progression of HIV disease in a haemophilic cohort followed for 11 years and the effect of treatment.
    Lee CA; Phillips AN; Elford J; Janossy G; Griffiths P; Kernoff P
    BMJ; 1991 Nov; 303(6810):1093-6. PubMed ID: 1781870
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Clinical and immunological features of human immunodeficiency virus infection in patients from Bangkok, Thailand.
    Wannamethee SG; Sirivichayakul S; Phillips AN; Ubolyam S; Ruxrungtham K; Hanvanich M; Phanuphak P
    Int J Epidemiol; 1998 Apr; 27(2):289-95. PubMed ID: 9602412
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Surrogate markers for survival in patients with AIDS and AIDS related complex treated with zidovudine.
    Jacobson MA; Bacchetti P; Kolokathis A; Chaisson RE; Szabo S; Polsky B; Valainis GT; Mildvan D; Abrams D; Wilber J
    BMJ; 1991 Jan; 302(6768):73-8. PubMed ID: 1671651
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Evaluation of the results of treatment of SSPE (subacute sclerosing panencephalitis) with isoprinosine].
    Filipowicz A; Grudzińska B
    Neurol Neurochir Pol; 1987; 21(4-5):352-6. PubMed ID: 2451185
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Survival of patients with zidovudine resistant HIV].
    Gøtzsche PC; Nielsen C; Gerstoft J; Nielsen CM; Vestergaard BF
    Ugeskr Laeger; 1994 Jan; 156(2):185-6. PubMed ID: 7905217
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Predictors of rapid progression to AIDS in HIV-1 seroconverters.
    Keet IP; Krijnen P; Koot M; Lange JM; Miedema F; Goudsmit J; Coutinho RA
    AIDS; 1993 Jan; 7(1):51-7. PubMed ID: 8095146
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.